5-Bromovilardin je agonist kainatnih receptora.[3]

5-Bromovilardin
(2S)-2-amino-3-(5-bromo-2,4-dioksopirimidin-1-il)propanoinska kiselina
Nazivi
IUPAC naziv
(2S)-2-amino-3-(5-bromo-2,4-dioksopirimidin-1-il)propanoinska kiselina
Drugi nazivi
  • Bromo-Vilardin
  • 5-Bromovilardin
  • 19772-78-2
  • QGW9M0L9SJ
  • CHEMBL333964
Identifikacija
3D model (Jmol)
  • C1=C(C(=O)NC(=O)N1CC(C(=O)O)N)Br
Svojstva
C7H8BrN3O4
Molarna masa 278,06 g·mol−1
Ukoliko nije drugačije napomenuto, podaci se odnose na standardno stanje materijala (na 25 °C [77 °F], 100 kPa).
Reference infokutije

Reference

уреди
  1. ^ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today. 15 (23-24): 1052—7. PMID 20970519. doi:10.1016/j.drudis.2010.10.003.  уреди
  2. ^ Evan E. Bolton; Yanli Wang; Paul A. Thiessen; Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry. 4: 217—241. doi:10.1016/S1574-1400(08)00012-1. 
  3. ^ D. E. Jane; H. W. Tse; D. A. Skifter; J. M. Christie; D. T. Monaghan. Pharmacology of Ionic Channel Function: Activators and Inhibitors. Glutamate Receptor Ion Channels: Activators and Inhibitors. Pharmacology of Ionic Channel Function: Activators and Inhibitors. Springer. стр. 415—478.